Niels Boone speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about the assessments of biosimilar monoclonal antibodies from a pharmacist's perspective.

He explains the pharmacist's perspective and how this differs from the physician's.

Boone also mentions how communication between disciplines is needed to successfully implement these agents in the clinic, as well as to educate patients.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.